c-19-press

Back to homepage

WHO: Joint Statement from Unitaid and the World Health Organization (on behalf of the Access to COVID-19 Tools Accelerator) regarding availability of tocilizumab

WHO and Unitaid are concerned by Roche’s statement yesterday, warning of a global shortage of tocilizumab (brand name Actemra/RoActemra), an IL6 inhibitor WHO recommended in June for use as a treatment for severe COVID-19 cases. Tocilizumab can play a key role in decreasing mortality

Read More

WTO: Goods Barometer hits record high, confirming strength of trade recovery

Global merchandise trade is continuing its robust recovery from the shock of the COVID-19 pandemic according to the WTO’s Goods Trade Barometer, which hit a record high in its latest reading issued on 18 August. The Goods Trade Barometer is

Read More

European Commission on State aid: Commission gives green light to new synthetic securitisation product under the European Guarantee Fund to further support SMEs affected by the coronavirus outbreak in 22 Member States

The European Commission approved, under EU State aid rules, the introduction of a new  product in the the form of guarantees on synthetic securitisation tranches under the European Guarantee Fund managed by the European Investment Bank Group (consisting of the

Read More

Managing Director Kristalina Georgieva’s Statement on the Summit of the Heads of State of the Economic and Monetary Community of Central Africa (CEMAC)

Fruitful discussions with Central African States Leaders on the economic impact of the pandemic and the challenges facing the region. Discussions also focused on the need to create job opportunities, improve living standards, and strengthen transparency. The IMF remains a

Read More

Multilateral Leaders Task Force on Covid-19 Vaccines, Therapeutics, and Diagnostics

A global effort to help developing countries access and deliver COVID-19 vaccines, testing, and therapeutics, as they work to end the pandemic and boost economic recovery. The International Monetary Fund, World Bank Group, World Health Organization and World Trade Organization

Read More

WHO Statement on advancing the next series of studies to find the origins of SARS-CoV-2

Since the start of the COVID-19 pandemic, WHO has been working with Member States and the scientific community to better understand how this pandemic began so that we can be better prepared for the next one. Following the publication of

Read More

IFC Insights: Accelerating a Strategy to Produce PPE in Africa

By Gary Seidman Paul Adedoyin Odunaiya, born and educated in Nigeria, spent most of his professional life working in the United Kingdom. Though he was trained as an accountant, he managed businesses in diverse fields, including IT, energy, and marketing.

Read More

IMF Blog: Putting Public Investment to Work

By Mariano Moszoro For countries on the path to recovery, reviving economic activity is a major priority. And what better way to support a come-back than by creating jobs. Our new IMF staff research shows that when governments spend on infrastructure, they create many

Read More

WHO’s Solidarity clinical trial enters a new phase with three new candidate drugs

Solidarity PLUS trial for promising drugs will roll out in 52 countries, an unprecedented global collaboration for COVID-19 R&D The World Health Organization (WHO) has announced the next phase in its Solidarity trial: Solidarity PLUS will enroll hospitalized patients to

Read More

IMF: Fault Lines Widen in the Global Recovery

Economic prospects have diverged further across countries since the April 2021 World Economic Outlook (WEO) forecast. Vaccine access has emerged as the principal fault line along which the global recovery splits into two blocs: those that can look forward to

Read More